ResMed (RMD) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $177.43 -0.1%
Revenue Growth %: +4.8%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +4.8%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $380.4 million versus the consensus estimate of $375 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
- Acme United (ACU) Misses Q1 EPS by 20c
- P&G lifts annual profit forecast on strong US consumer demand, easing costs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
